Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) EBT (2016 - 2025)

Nu-Med Plus' EBT history spans 10 years, with the latest figure at -$112341.0 for Q4 2021.

  • On a quarterly basis, EBT rose 77.87% to -$112341.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$839445.0, a 58.59% increase, with the full-year FY2025 number at -$56182.0, up 17.8% from a year prior.
  • EBT hit -$112341.0 in Q4 2021 for Nu-Med Plus, up from -$118366.0 in the prior quarter.
  • Over the last five years, EBT for NUMD hit a ceiling of $3.9 million in Q4 2017 and a floor of -$912488.0 in Q2 2020.
  • Historically, EBT has averaged -$72956.4 across 5 years, with a median of -$186876.0 in 2018.
  • Biggest five-year swings in EBT: surged 315.52% in 2017 and later crashed 290.35% in 2018.
  • Tracing NUMD's EBT over 5 years: stood at $3.9 million in 2017, then tumbled by 108.98% to -$350409.0 in 2018, then skyrocketed by 40.1% to -$209881.0 in 2019, then crashed by 141.9% to -$507696.0 in 2020, then skyrocketed by 77.87% to -$112341.0 in 2021.
  • Business Quant data shows EBT for NUMD at -$112341.0 in Q4 2021, -$118366.0 in Q3 2021, and -$251990.0 in Q2 2021.